dc.contributorUniversity of California
dc.contributorCalifornia Health and Food Safety Laboratory
dc.contributorUniversidade Estadual Paulista (Unesp)
dc.date.accessioned2014-05-27T11:26:26Z
dc.date.available2014-05-27T11:26:26Z
dc.date.created2014-05-27T11:26:26Z
dc.date.issued2012-04-01
dc.identifierJournal of Veterinary Pharmacology and Therapeutics, v. 35, n. 2, p. 163-168, 2012.
dc.identifier0140-7783
dc.identifier1365-2885
dc.identifierhttp://hdl.handle.net/11449/73244
dc.identifier10.1111/j.1365-2885.2011.01301.x
dc.identifier2-s2.0-84857993948
dc.description.abstractThis study reports the effects of dexmedetomidine on the minimum alveolar concentration of isoflurane (MAC iso) in cats. Six healthy adult female cats were used. MAC iso and dexmedetomidine pharmacokinetics had previously been determined in each individual. Cats were anesthetized with isoflurane in oxygen. Dexmedetomidine was administered intravenously using target-controlled infusions to maintain plasma concentrations of 0.16, 0.31, 0.63, 1.25, 2.5, 5, 10, and 20ng/mL. MAC iso was determined in triplicate at each target plasma dexmedetomidine concentration. Blood samples were collected and analyzed for dexmedetomidine concentration. The following model was fitted to the concentration-effect data: where MAC iso.c is MAC iso at plasma dexmedetomidine concentration C, MAC iso.0 is MAC iso in the absence of dexmedetomidine, I max is the maximum possible reduction in MAC iso, and IC 50 is the plasma dexmedetomidine concentration producing 50% of I max. Mean±SE MAC iso.0, determined in a previous study conducted under conditions identical to those in this study, was 2.07±0.04. Weighted mean±SE I max, and IC 50 estimated by the model were 1.76±0.07%, and 1.05±0.08ng/mL, respectively. Dexmedetomidine decreased MAC iso in a concentration-dependent manner. The lowest MAC iso predicted by the model was 0.38±0.08%, illustrating that dexmedetomidine alone is not expected to result in immobility in response to noxious stimulation in cats at any plasma concentration. © 2011 Blackwell Publishing Ltd.
dc.languageeng
dc.relationJournal of Veterinary Pharmacology and Therapeutics
dc.relation1.441
dc.relation0,700
dc.relation0,700
dc.rightsAcesso restrito
dc.sourceScopus
dc.subjectdexmedetomidine
dc.subjectisoflurane
dc.subjectanimal experiment
dc.subjectconcentration response
dc.subjectcontrolled study
dc.subjectdrug blood level
dc.subjectdrug potentiation
dc.subjectexperimental cat
dc.subjectfemale
dc.subjectIC 50
dc.subjectminimum lung alveolus concentration
dc.subjectnonhuman
dc.subjectpriority journal
dc.subjectAnalgesics, Non-Narcotic
dc.subjectAnesthesia, Inhalation
dc.subjectAnesthetics, Inhalation
dc.subjectAnimals
dc.subjectCats
dc.subjectDexmedetomidine
dc.subjectDose-Response Relationship, Drug
dc.subjectDrug Interactions
dc.subjectFemale
dc.subjectIsoflurane
dc.subjectPulmonary Alveoli
dc.titleEffect of dexmedetomidine on the minimum alveolar concentration of isoflurane in cats
dc.typeArtículos de revistas


Este ítem pertenece a la siguiente institución